Biden administration announces $15 million in humanitarian assistance for Palestinians to respond to COVID-19

The Biden administration on Thursday announced $15 million in humanitarian assistance for Palestinians to respond to COVID-19 in the West Bank and Gaza Strip. 

The State Department said the U.S. Agency for International Development (USAID) would be providing the funds to address the most urgent, life-saving humanitarian needs in the West Bank and Gaza. 

“With this assistance, USAID is supporting Catholic Relief Services’ COVID-19 response efforts in health care facilities and affected communities throughout the West Bank and Gaza. This assistance is also supporting emergency food assistance programming in communities facing food insecurity, which has been exacerbated by the COVID-19 pandemic.  This small step in advancing the well-being of the Palestinian people is fully in keeping with American values,” the state department said.

It added: Additionally, to date, the United States has provided an initial $2 billion contribution to Gavi, the global vaccine alliance, to support vaccination for people around the world through the COVAX Advanced Market Commitment.  In mid-March, the Palestinian Authority received the first batch of AstraZeneca and Pfizer/BioNTech COVID-19 vaccines through the COVAX AMC.  This is part of COVAX’s commitment to provide a total 168,000 AstraZeneca and 37,440 Pfizer/BioNTech vaccine doses for the West Bank and Gaza.  Global cooperation is crucial to meet the threats of our time.  President Biden is committed to working with our partners on COVID-19, a top national security priority.”

Chief White House Correspondent for

Simon Ateba is Chief White House Correspondent for Today News Africa. Simon covers President Joe Biden, Vice President Kamala Harris, the U.S. government, the United Nations, the International Monetary Fund, the World Bank and other financial and international institutions in Washington D.C. and New York City.

Show More
error: Alert: Share This Content !!

Adblock Detected

Please consider supporting us by disabling your ad blocker